ZAZZERONI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 6.690
EU - Europa 4.415
AS - Asia 3.819
SA - Sud America 457
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 15.457
Nazione #
US - Stati Uniti d'America 6.585
SG - Singapore 1.516
RU - Federazione Russa 906
CN - Cina 872
IE - Irlanda 814
IT - Italia 587
DE - Germania 465
TR - Turchia 438
HK - Hong Kong 413
BR - Brasile 402
SE - Svezia 399
VN - Vietnam 325
FR - Francia 309
GB - Regno Unito 293
UA - Ucraina 213
FI - Finlandia 190
IN - India 68
CA - Canada 52
JP - Giappone 47
CZ - Repubblica Ceca 44
BE - Belgio 39
MX - Messico 34
PL - Polonia 34
NL - Olanda 31
ES - Italia 26
BD - Bangladesh 21
ZA - Sudafrica 21
IQ - Iraq 19
AR - Argentina 16
AT - Austria 13
KR - Corea 13
LT - Lituania 13
EU - Europa 10
ID - Indonesia 10
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
PK - Pakistan 8
CH - Svizzera 7
IL - Israele 7
MY - Malesia 7
UZ - Uzbekistan 7
DZ - Algeria 6
KE - Kenya 6
PT - Portogallo 6
PY - Paraguay 6
TN - Tunisia 6
AU - Australia 5
AZ - Azerbaigian 5
CO - Colombia 5
JO - Giordania 5
PA - Panama 5
PH - Filippine 5
SA - Arabia Saudita 5
CL - Cile 4
EG - Egitto 4
LB - Libano 4
MA - Marocco 4
DK - Danimarca 3
IR - Iran 3
JM - Giamaica 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RO - Romania 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BZ - Belize 1
CM - Camerun 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
Totale 15.451
Città #
Chandler 864
Singapore 859
Jacksonville 819
Dublin 806
Dallas 744
San Jose 627
Hong Kong 407
Ashburn 397
Boardman 334
Santa Clara 310
Izmir 191
Nanjing 159
The Dalles 155
New York 141
San Mateo 135
Moscow 133
Beijing 126
Wilmington 117
Munich 116
Lawrence 114
Princeton 114
Ann Arbor 105
Ho Chi Minh City 103
Lauterbourg 88
Los Angeles 88
L'aquila 78
L’Aquila 75
Hanoi 70
Council Bluffs 61
Nanchang 60
Bremen 59
Milan 55
Helsinki 54
Woodbridge 53
Aquila 48
Tokyo 45
Shenyang 44
Brno 43
São Paulo 42
Rome 41
Brussels 39
Hefei 37
Orem 34
Verona 34
Mountain View 33
Seattle 31
Warsaw 31
Shanghai 29
Dong Ket 28
Jiaxing 28
Hebei 27
London 27
Tianjin 27
Turku 24
Frankfurt am Main 23
Atlanta 22
Columbus 22
Des Moines 22
Montreal 22
Houston 21
Kunming 21
Zhengzhou 20
Brooklyn 19
Changsha 19
Chennai 19
Amsterdam 18
Denver 18
Johannesburg 18
Ningbo 18
Dearborn 17
Haiphong 17
Assago 16
Da Nang 16
Lappeenranta 16
Kitzingen 15
Pescara 15
Poplar 15
Casoria 14
Chicago 13
Jinan 13
Mexico City 13
Norwalk 13
Phoenix 13
Teramo 13
Belo Horizonte 12
San Francisco 12
Stockholm 12
Vienna 12
Guangzhou 11
Manchester 11
Nuremberg 11
Toronto 11
Boston 10
Querétaro 10
Falkenstein 9
Hangzhou 9
Mumbai 9
Redmond 9
Auburn Hills 8
Berlin 8
Totale 9.994
Nome #
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 184
GADD45β loss ablates innate immunosuppression in cancer 178
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 176
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 175
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 173
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 171
Therapeutic Use of MicroRNAs in Cancer 167
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 160
The NF-kappaB-mediated control of ROS and JNK signaling 158
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 157
Ruolo del gene oncosoppressore KCTD11REN(KCTD11) nel carcinoma prostatico umano. 156
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 156
Adipose-derived stem cells sustain prolonged angiogenesis through leptin secretion 155
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 153
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 153
Emerging role of isomirs in cancer: State of the art and recent advances 152
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 150
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 147
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 146
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 146
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy 144
Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not intefere with ongoing lymphocytes apoptosis 143
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 142
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 141
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 141
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 139
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 139
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 139
Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients 135
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 135
The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors. 134
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 132
Immunohistochemical Analysis of Expression, Phosphorylation, and Nuclear Translocation of NF-κB Proteins in Human Tissues 131
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 130
Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2 130
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 130
Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells 129
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 127
Ultrasound-based method for the identification of novel microrna biomarkers in prostate cancer 127
Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures 126
NF-κB: A Druggable Target in Acute Myeloid Leukemia 126
Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation 126
crosstalk between nf-kb and shh pathways in prostate cancer 126
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 122
2-Aminopurine unravels a role for pRB in the regulation of gene expression by transforming growth factor beta 122
the role of kctd11 tumor suppressor gene in prostate cancer 122
Improved tissue culture method for the study of prostatic carcinoma: a significant diagnostic tool 121
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 121
Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis 120
UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND METALLOPROTEINASE (MMP-9) PRODUCTION IS IN-CREASED IN SHORT TERM CULTURES OF HUMAN PROSTATIC CARCINOMA. 120
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 119
JNK: a killer on a transcriptional leash 118
Biochemical Methods to Analyze the Subcellular Localization of NF-κB Proteins Using Cell Fractionation 118
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 117
FINASTERIDE REDUCES GROWTH RATE OF HUMAN PROSTATIC CARCINOMA IN VITRO 117
Turning an old GADDget into a troublemaker 117
Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression 116
Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study 116
Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation by peripheral blood lymphocytes from AIDS patients. 116
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 116
The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering 116
Targeting costimulatory molecules to improve antitumor immunity. 115
Analisi del miRNoma nell’epatocarcinogenesi indotta da dietilnotrosamina. 115
Basal cell carcinoma and inflammation: role of the Gadd45b gene 115
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 115
Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species 114
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 114
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 114
Life, death, and autophagy in cancer: NF-κB turns up everywhere 114
Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis 113
Cell signalling (communication arising) - Cell survival and a Gadd45-factor deficiency - Reply 113
A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells 113
Identification of Novel Factors that Block Programmed Cell Death or Apoptosis by Targeting JNK 112
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma 111
Apoptosis or programmed cell death 111
A method for isolating prosurvival targets of NF-kappaB/Rel transcription factors 111
Regolazione trascrizionale ed epigenetica del gene oncosoppressore KCTD11REN. 110
The Screening of Combinatorial Peptide Libraries for Targeting Key Molecules or Protein–Protein Interactions in the NF-κB Pathway 110
Characterization and biologic role of REN, a novel gene involved in neural cell differentiation 109
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 109
Analisi del miRNoma nell’epatocarcinogenesi indotta da dietilnotrosamina. 108
Extracellular Flux Analysis to Investigate the Impact of NF-κB on Mitochondrial Respiration in Colorectal Carcinoma (CRC) 107
MicroRNAs in the DNA Damage/Repair Network and Cancer 106
The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity 106
REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma 105
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 105
Induction of gadd45 beta by NF-kappa B down-regulates pro-apoptotic JNK signaling 105
Possibile anti-apoptotic activity of carnitines on excitatory amino acid induced neurotoxicity 105
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 104
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer 104
REN: a novel, developmentally regulated gene that promotes neural cell differentiation 103
Intranasal delivery of NGF rescues hearing impairment in aged SAMP8 mice 103
EGF regulates a complex pattern of gene expression and represses smooth muscle differentiation during the neurotypic conversion of the neural-crest-derived TC-1S cell line 102
The tumor suppressor gene KCTD11 REN is regulated by SP1 and methylation and its expression is reduced in tumors 102
Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling 102
Effect of l-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from aids patients: correlation with in vitro results 101
Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study 101
Ultrasound as a New Method for the Release and Identification of Novel microRNAs and Proteins as Candidate Biomarkers in Pancreatic Cancer 100
Upregulation of Twist-1 by NF-{kappa}B Blocks Cytotoxicity Induced by Chemotherapeutic Drugs 100
NF-κB: Governing Macrophages in Cancer 99
Totale 12.625
Categoria #
all - tutte 62.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021297 0 0 0 0 0 0 0 0 0 47 182 68
2021/2022754 46 65 159 64 49 6 12 50 47 23 50 183
2022/20232.456 148 156 35 304 266 253 6 133 1.021 13 84 37
2023/2024619 72 26 31 91 35 133 18 64 4 23 22 100
2024/20252.733 87 85 253 123 289 206 365 241 541 158 199 186
2025/20265.295 260 555 558 766 537 443 836 168 434 738 0 0
Totale 15.670